Progression to a severe form of COVID-19 among patients with chronic respiratory diseases: a French multicentric study.

S. Basin (NANCY, France), S. Valentin (NANCY, France), A. Maurac (NANCY, France), M. Poussel (NANCY, France), B. Pequignot (NANCY, France), A. Brindel (NANCY, France), C. Robert (METZ, France), C. Baumann (NANCY, France), A. Luc (NANCY, France), J. Soler (NANCY, France), F. Chabot (NANCY, France), A. Chaouat (NANCY, France)

Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Session: Epidemiology and burden of tuberculosis and other lung diseases
Session type: E-poster
Number: 1734

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Basin (NANCY, France), S. Valentin (NANCY, France), A. Maurac (NANCY, France), M. Poussel (NANCY, France), B. Pequignot (NANCY, France), A. Brindel (NANCY, France), C. Robert (METZ, France), C. Baumann (NANCY, France), A. Luc (NANCY, France), J. Soler (NANCY, France), F. Chabot (NANCY, France), A. Chaouat (NANCY, France). Progression to a severe form of COVID-19 among patients with chronic respiratory diseases: a French multicentric study.. 1734

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role and distribution of infectious agents in exacerbations of moderate, severe and very severe forms of chronic obstructive lung disease: a prospective trial
Source: Eur Respir J 2006; 28: Suppl. 50, 735s
Year: 2006

Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study.
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
Source: Eur Respir J, 58 (6) 2004474; 10.1183/13993003.04474-2020
Year: 2021



Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry
Source: Eur Respir J 2001; 18: Suppl. 33, 510s
Year: 2001

Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study.
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Prospective study of infectious bacterial etiology of acute exacerbation of chronic obstructive pulmonary disease in India
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


Impact of Candida isolation in lower respiratory tract samples on the outcomes of acute exacerbation of chronic obstructive pulmonary disease: a retrospective case-control study
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020

PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Nutritional status in patients with chronic obstructive pulmonary disease - a first multi-centre experience in Croatia
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Respiratory symptoms and CRP among participants of the English longitudinal study of ageing (ELSA) – ageing or occult disease?
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007


Undetected chronic obstructive lung disorders in patients presenting with acute cough in primary care: Results from the European GRACE study
Source: Annual Congress 2011 - Appropriate use of antibiotics in respiratory infections in Europe (the GRACE project)
Year: 2011

Impact of steroid therapy on exacerbation of chronic obstructive pulmonary disease with community-onset pneumonia: a multicenter retrospective cohort study
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


Exacerbations and symptoms remain common in patients with asthma control: A survey of 8000 patients in Europe
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013


Measurement properties of exacerbations of chronic pulmonary disease tool (EXACT) in a clinical trial of patients with moderate to severe COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013


Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016


Case control study of chronic obstructive pulmonary disease and its progression
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013

Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016